Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer.
Havva SezerDilek Dereli YazıcıOguzhan DeyneliÇişel MeriçözAyla EsinEmrah AlperPublished in: Endokrynologia Polska (2020)
Not required for Clinical Vignette.